Wall Street Analysts Think Apogee Therapeutics Inc. (APGE) Could Surge 132.72%: Read This Before Placing a Bet

Apogee Therapeutics Inc. (APGE) closed the last trading session at $40.34, gaining 13.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 93.88 indicates a 132.7% upside potential.The average comprises eight short-term price targets ranging from a low of $78 to a high of$ 116, with a standard deviation of $11.05. While the lowest estimate indicates an increase of 93.4% from the cur ...